罗永浩自曝患病服药十几年，如今最大剂量也“不太管用”？医生：他的病无短期内治愈方法，所用药受到严格管制

Group 1: Event Overview - The 2025 Technology Innovation Sharing Conference hosted by Luo Yonghao was held in Shanghai, but he arrived over 40 minutes late [1] - Luo Yonghao announced a full refund for ticket prices ranging from 300 to 1000 yuan and apologized, stating he would write a confession letter [4] Group 2: ADHD and Treatment Insights - According to the 2023 edition of the "Expert Consensus on the Diagnosis and Treatment of Adult ADHD in China," the prevalence of ADHD among adults in China is approximately 3% [3][6] - The primary treatment methods for ADHD include medication, psychotherapy, and behavioral training, with medication being one of the most effective approaches [3][8] - The medication mentioned by Luo Yonghao, "Zhuanzhu Da," is a sustained-release formulation of methylphenidate, which is a first-line treatment for ADHD [3][8] Group 3: Challenges in ADHD Treatment - There is currently no short-term cure for ADHD, and it requires long-term management and comprehensive treatment [5][9] - The existing treatment landscape in China lacks superior alternative medications, with the only approved sustained-release methylphenidate product being "Zhuanzhu Da," which has been on the market since 2005 [8][11] - The supply of "Zhuanzhu Da" has faced instability, leading to medication shortages and anxiety among patients and their families [9] Group 4: Market Dynamics and Developments - The sales revenue for ADHD medications in domestic sample hospitals was approximately 350 million yuan in 2023, with a further increase to about 430 million yuan in the first three quarters of 2024 [10] - Domestic pharmaceutical companies are increasingly focusing on the ADHD treatment market, with Lifan Pharmaceutical launching the first generic version of sustained-release methylphenidate, breaking a 20-year monopoly [11] - Other companies, such as Huazhong Shuanghe and Suzhou No. 1 Pharmaceutical, hold production licenses for regular formulations of methylphenidate, but these are less effective than sustained-release versions [11]